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Abstract 
Preformed antibodies directed at donor HLA are considered an absolute contraindication for kidney 
transplantation, because of the high risk of rejection. Thus, patients with high levels of HLA 
antibodies have little chance of receiving a kidney transplant. Recently it was demonstrated that an 
auxiliary liver graft from the same donor may protect a subsequently grafted kidney from these 
harmful antibodies. The aim of this thesis was to elucidate the mechanisms behind the kidney 
protection afforded by the auxiliary liver graft in highly sensitized patients. We focused on the 
activation of dendritic cells, because these cells, which reside in all peripheral tissues, play a key 
role in the initiation of an immune response.  
This thesis demonstrates that gene expression in the liver graft correlates with clinical outcome: In 
patients without an acute rejection episode, 14 out of 45 investigated immunological genes were 
significantly higher expressed in the liver graft 4h after reperfusion, compared with patients that 
experienced an acute rejection episode within the first month. This indicates that high- and low-risk 
patients can be identified within hours after transplantation.  
One gene of particular interest was indoleamine 2,3-dioxygenase (IDO), which is a tolerance-
inducing enzyme previously found to play a key role in maintenance of semi-allogeneic pregnancy 
in mice. In our study, mRNA levels of IDO were strongly upregulated in patients after combined 
auxiliary liver-kidney transplantation and IDO expression in the liver graft correlated with clinical 
outcome. Furthermore, IDO activity was higher in patients after combined auxiliary liver-kidney 
transplantation and liver transplantation compared with patients undergoing kidney transplantation. 
Strongly increased serum levels of the anti-inflammatory cytokine interleukin (IL) 10 were also 
found after liver but not kidney transplantation. IL-10 has several immune inhibitory effects on 
dendritic cells. We found that IL-10 inhibited the production of chemokines MIG, IP-10 and I-TAC 
in monocyte-derived dendritic cells in vitro. When comparing different cytokine cocktails for 
dendritic cell maturation, we showed that MIG, IP-10 and I-TAC were essential for dendritic cell-
mediated recruitment of natural killer (NK) cells. This is considered important for the initiation of a 
type 1 T helper cell response. We also showed that IL-10 treated dendritic cells, which expressed 
less of these chemokines, had reduced potential to activate NK cells.  
Thus, the liver provides IDO and IL-10, both of which have the ability to reduce the 
immunostimulatory ability of dendritic cells, giving them a tolerance-promoting profile. We 
therefore suggest that the protective effect of an auxiliary liver in presensitized patients may, at least 
in part, be mediated by the liver-specific expression of IDO and IL-10. 
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